Headlines Tagged with Inflammation/infections/immunity — 805 headlines found
Patients with recurrent mouth and throat cancers are more likely to survive if the tumors are caused by the human papillomavirus (HPV) and not smoking, according to new research.
Feb 20, 2014 HealthDay [HealthScout]
added Feb 26, 2014 23:12
Dr. Barsky's testimony ... He accepted as a "ball park figure" that 90% of lung cancers were caused by smoking. He comfortably volunteered that he had never doubted the the link between smoking and lung cancer, and that he was aware that the companies ha
Feb 18, 2014 Eye on the Trials (ASPQ) (ca)
added Feb 19, 2014 09:42
Today I learned that the financial rewards can be sizable. Dr. Barsky said he had earned over $3 million over the 20 years he has consulted ... Lung cancer is caused by lots of things. Sometimes there is no outside cause. You can only know if a cancer wa
Feb 17, 2014 Eye on the Trials (ASPQ) (ca)
added Feb 19, 2014 09:38
Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study [FREE FULL TEXT]
Survivin is a relevant and reproducible marker of severe RA. Persistently high levels of survivin were associated with smoking and the presence of aCCP and/or RF antibodies and predicted persistent disease activity and joint damage.
Jan 16, 2014 Arthritis Research & Therapy (uk)
added Jan 23, 2014 16:49
Conclusions Coffee consumption and smoking might protect against development of PSC. In women, the disease might be influenced by hormonal factors.
Sep 27, 2013 Clinical Gastroenterology and Hepatology
added Dec 14, 2013 18:14
Coffee and cigarette smoking may protect against the rare liver disease Primary Sclerosing Cholangitis (PSC), study shows. In a new study from Norway published in Clinical Gastroenterology and Hepatology, both coffee consumption and cigarette smoking are
Dec 14, 2013 ScienceDaily
added Dec 14, 2013 17:46
Sep 30, 2013 Medical Tribune
added Nov 10, 2013 18:39
Dr. Ramalingam: The early data from studies of PD-1- and PD-L1-targeted agents have been exciting and encouraging, with single-agent response rates of 20% among all enrolled patients. In addition, many of the responding patients remain on therapy with
Oct 30, 2013 Medical Tribune
added Nov 9, 2013 14:24
Early promising results with immunotherapy are making these "exciting times" in the treatment of non-small cell lung cancer (NSCLC), several experts commented here at the 15th World Conference on Lung Cancer.
Oct 31, 2013 Medical Tribune
added Nov 9, 2013 14:21
Star Scientific and Rock Creek Pharmaceuticals Announce the Publication of a Peer-Reviewed Article about the ASAP Clinical Trial Showing Immune System Support in Hashimoto's Thyroiditis
a three-month, IRB-approved, five-visit, double-blind, randomized, placebo-controlled, multi-site study evaluating the impact of anatabine dietary supplementation in patients with Hashimoto's thyroiditis, one of the most common autoimmune diseases and a
Oct 31, 2013 PR Newswire
added Nov 5, 2013 06:29